BLOG

biospace

Preparing a Pandemic Plan for Whatever Comes Our Way Next

Which is why OSE Immunotherapeutics is developing a vaccine that aims to be pan-coronavirus. The formulation for CoVepiT, which focuses on inducing a lasting T cell immune response, is made up of 11 total viral targets. This way, even if one changes, there are still 10 other potentially valid targets.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}